Texas Democratic Senate candidate James Talarico announced on Wednesday that his campaign raised $30 million in the second quarter of 2026, more than tripling the $9 million raised by Republican rival Ken Paxton in the same period. The fundraising surge comes as both campaigns prepare for a competitive November election to succeed outgoing Sen. John Cornyn (R-TX). If elected, Talarico would be the first Democrat to win a statewide race in Texas since 1988.
Immediate Action & Core Facts
Talarico’s campaign described the $30 million haul as a record for a U.S. Senate candidate in the second quarter of an election year. Paxton’s campaign confirmed his $9 million total, which was significantly lower but still substantial. The race remains statistically tight, with polls showing a dead heat and prediction markets favoring Paxton slightly.
Deeper Dive & Context
Polling and Prediction Markets
Recent polling shows a narrow margin between the candidates. An A2 Insights survey puts Talarico at 48.4% and Paxton at 46.1%, while a SoCal Strategies poll shows Paxton leading 49% to 47%. Prediction markets currently give Paxton a 61% chance of winning, compared to 41% for Talarico.
Historical and Political Context
Texas has long been a Republican stronghold, but recent elections have grown more competitive due to demographic and political shifts. Talarico’s fundraising success underscores Democratic optimism, though polling suggests the state’s Republican leanings still pose a significant challenge.
Campaign Responses
Neither campaign has publicly commented on the fundraising disparity beyond releasing their respective totals. The Talarico campaign emphasized the historic nature of the haul, while Paxton’s campaign did not provide additional context.
Implications for the Race
The fundraising gap could intensify outreach, advertising, and turnout efforts ahead of November. Talarico’s ability to raise such a large sum suggests strong grassroots support, while Paxton’s lower total may reflect broader Republican concerns about his candidacy.